The role of cognitive impairment and caregiver support in diabetes management of older outpatients

International Journal of Psychiatry in Medicine

Volumn 39, Issue 2, 2009, Pages 199-214

  Feil, Denise G ^a   Pearman, Ann ^b   Victor, Tara ^c   Harwood, Dylan ^d   Weinreb, Jane ^a   Kahle, Kristin ^e   Unützer, Jürgen ^f  

^a West Los Angeles Veterans Health Care Center   (United States)

^b GEORGIA STATE UNIVERSITY   (United States)

^c CALIFORNIA STATE UNIVERSITY   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^f UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Caregivers; Cognitive impairment; Dementia; Diabetes mellitus; Self care

Indexed keywords

HEMOGLOBIN A1C;

ADULT; AGED; AGING; ARTICLE; BLOOD LEVEL; CAREGIVER SUPPORT; COGNITIVE DEFECT; CONTROLLED STUDY; DEPRESSION; ELECTRONIC MEDICAL RECORD; GLYCEMIC CONTROL; HUMAN; INFORMATION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTPATIENT CARE; PATIENT COMPLIANCE; ROLE PLAYING; SELF CARE;

AGED; AGED, 80 AND OVER; CAREGIVERS; COGNITION DISORDERS; COMORBIDITY; CROSS-SECTIONAL STUDIES; DEPRESSIVE DISORDER; DIABETES MELLITUS, TYPE 2; FEMALE; HEALTH SERVICES NEEDS AND DEMAND; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LONGITUDINAL STUDIES; LOS ANGELES; MALE; MIDDLE AGED; PATIENT COMPLIANCE; QUALITY OF LIFE; SELF CARE; SOCIAL SUPPORT; VETERANS;

EID: 70350336698     PISSN: 00912174     EISSN: 15413527     Source Type: Journal    
DOI: 10.2190/PM.39.2.h     Document Type: Article

References (37)

1. Narayan KM, Boyle JP, Geiss LS, Saaddine JB, Thompson TJ. Impact of recent increase in incidence on future diabetes burden: U. S., 2005-2050. Diabetes Care 2006;29(9):2114-2116.
2. Plassman BL, Langa KM, Fisher GG, Heeringa SG, Weir DR, Ofstedal MB, Burke JR, Hurd MD, Potter GG, Rodgers WL, Steffens DC, Willis RJ, Wallace RB. Prevalence of dementia in the United States: The aging, demographics, and memory study. Neuroepidemiology 2007;29(1-2):125-132.
3. Fontbonne A, Berr C, Ducimetiere P, Alperovitch A. Changes in cognitive abilities over a 4-year period are unfavorably affected in elderly diabetic subjects: Results of the Epidemiology of Vascular Aging Study. Diabetes Care 2001;24(2):366-370.
4. Luchsinger JA, Reitz C, Honig LS, Tang MX, Shea S, Mayeux R. Aggregation of vascular risk factors and risk of incident Alzheimer disease. Neurology 2005; 65(4):545-551.
5. Schnaider BM, Goldbourt U, Silverman JM, Noy S, Schmeidler J, Ravona-Springer R, Sverdlick A, Davidson M. Diabetes mellitus in midlife and the risk of dementia three decades later. Neurology 2004;63(10):1902-1907.
6. MacKnight C, Rockwood K, Awalt E, McDowell I. Diabetes mellitus and the risk of dementia, Alzheimer's disease and vascular cognitive impairment in the Canadian Study of Health and Aging. Dementia and Geriatric Cognitive Disorders 2002; 14(2):77-83. (Pubitemid 36152948)
7. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998;352(9131):837-853.
8. Skaer TL, Sclar DA, Markowski DJ, Won JK. Effect of value-added utilities on prescription refill compliance and Medicaid health care expenditures-A study of patients with non-insulin-dependent diabetes mellitus. Journal of Clinical Pharmaceutical Therapy 1993;18(4):295-299.
9. Krapek K, King K, Warren SS, George KG, Caputo DA, Mihelich K, Holst EM, Nichol MB, Shi SG, Livengood KB, Walden S, Lubowski TJ. Medication adherence and associated hemoglobin A1c in type 2 diabetes. Annals of Pharmacotherapy 2004;38(9):1357-1362.
10. Pladevall M, Williams LK, Potts LA, Divine G, Xi H, Lafata JE. Clinical outcomes and adherence to medications measured by claims data in patients with diabetes. Diabetes Care 2004;27(12):2800-2805.
11. Sinclair AJ, Girling AJ, Bayer AJ. Cognitive dysfunction in older subjects with diabetes mellitus: Impact on diabetes self-management and use of care services. All Wales Research into Elderly (AWARE) Study 2. Diabetes Research and Clinical Practice 2000;50(3):203-212.
12. Rosen MI, Beauvais JE, Rigsby MO, Salahi JT, Ryan CE, Cramer JA. Neuropsychological correlates of suboptimal adherence to metformin. Journal of Behavioral Medicine 2003;26(4):349-360.
13. Teng EL, Hasegawa K, Homma A, Imai Y, Larson E, Graves A, Sugimoto K, Yamaguchi T, Sasaki H, Chiu D. The Cognitive Abilities Screening Instrument (CASI): A practical test for cross-cultural epidemiological studies of dementia. International Psychogeriatrics 1994;6(1):45-58.
14. Toobert DJ, Hampson SE, Glasgow RE. The summary of diabetes self-care activities measure: Results from 7 studies and a revised scale 2. Diabetes Care 2000;23(7):943-950.
15. Meadows KA, Abrams C, Sandbaek A. Adaptation of the Diabetes Health Profile (DHP-1) for use with patients with Type 2 diabetes mellitus: Psychometric evaluation and cross-cultural comparison. Diabetes Medicine 2000;17(8):572-580.
16. Miller MD, Paradis CF, Houck PR, Mazumdar S, Stack JA, Rifai AH, Mulsant B, Reynolds CF, III. Rating chronic medical illness burden in geropsychiatric practice and research: Application of the Cumulative Illness Rating Scale. Psychiatry Research 1992;41(3):237-248.
17. Alexopoulos GS, Abrams RC, Young RC, Shamoian CA. Use of the Cornell scale in nondemented patients. Journal of the American Geriatric Society 1988;36(3):230-236.
18. Alexopoulos GS, Abrams RC, Young RC, Shamoian CA. Cornell Scale for Depression in Dementia. Biology and Psychiatry 1988;23(3):271-284.
19. McCurry SM, Edland SD, Teri L, Kukull WA, Bowen JD, McCormick WC, Larson EB. The cognitive abilities screening instrument (CASI): Data from a cohort of 2524 cognitively intact elderly. International Journal of Geriatric Psychiatry 1999;14(10):882-888.
20. Cullen B, Fahy S, Cunningham CJ, Coen RF, Bruce I, Greene E, Coakley D, Walsh JB, Lawlor BA. Screening for dementia in an Irish community sample using MMSE: A comparison of norm-adjusted versus fixed cut-points. International Journal of Geriatric Psychiatry 2005;20(4):371-376.
21. van Gorp WG, Marcotte TD, Sultzer D, Hinkin C, Mahler M, Cummings JL. Screening for dementia: Comparison of three commonly used instruments. Journal of Clinical Experience in Neuropsychology 1999;21(1):29-38.
22. Riemsma RP, Forbes CA, Glanville JM, Eastwood AJ, Kleijnen J. General health status measures for people with cognitive impairment: Learning disability and acquired brain injury. Health Technology Assessment 2001;5(6):1-100.
23. Tager IB, Swanson A, Satariano WA. Reliability of physical performance and selfreported functional measures in an older population. Journal of Gerontology Series A Biology Science and Medical Science 1998;53(4):M295-M300.
24. Asimakopoulou KG, Hampson SE. Cognitive functioning and self-management in older people with diabetes. Diabetes Spectrum 2002;15:116-121.
25. Walker EA, Molitch M, Kramer MK, Kahn S, Ma Y, Edelstein S, Smith K, Johnson MK, Kitabchi A, Crandall J. Adherence to preventive medications: Predictors and outcomes in the Diabetes Prevention Program. Diabetes Care 2006;29(9): 1997-2002.
26. Gaugler JE, Kane RL, Kane RA, Newcomer R. The longitudinal effects of early behavior problems in the dementia caregiving career. Psychology of Aging 2005; 20(1):100-116. (Pubitemid 40389399)
27. Dorenlot P, Harboun M, Bige V, Henrard JC, Ankri J. Major depression as a risk factor for early institutionalization of dementia patients living in the community. International Journal of Geriatric Psychiatry 2005;20(5):471-478.
28. Yaffe K, Fox P, Newcomer R, Sands L, Lindquist K, Dane K, Covinsky KE. Patient and caregiver characteristics and nursing home placement in patients with dementia. Journal of the American Medical Association 2002;287(16):2090- 2097.
29. Dluhy RG, McMahon GT. Intensive glycemic control in the ACCORD and ADVANCE trials. New England Journal of Medicine 2008;358(24):2630-2633.
30. Management of diabetes mellitus in primary care: Module G. Glycemic control. In Clinical Practice Guidelines, Veterans Health Administration. Available at: http://www.oqp.med.va.gov/cpg/DM/DM3-cpg/content/ModG/modG-fr.htm; accessed July 7, 2008.
31. Brown AF, Mangione CM, Saliba D, Sarkisian CA. Guidelines for improving the care of the older person with diabetes mellitus. Journal of the American Geriatric Society 2003;51(5 Suppl Guidelines):S265-S280.
32. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34(7):939-944.
33. Poehlman ET, Dvorak RV. Energy expenditure, energy intake, and weight loss in Alzheimer disease. American Journal of Clinical Nutrition 2000;71(2):650S-655S.
34. Ciechanowski PS, Katon WJ, Russo JE. Depression and diabetes: Impact of depressive symptoms on adherence, function, and costs. Archives of Internal Medicine 2000;160(21):3278-3285.
35. Kalsekar ID, Madhavan SS, Amonkar MM, Makela EH, Scott VG, Douglas SM, Elswick BL. Depression in patients with type 2 diabetes: Impact on adherence to oral hypoglycemic agents. Annals of Pharmacotherapy 2006;40(4):605-611.
36. Lin EH, Katon W, Von KM, Rutter C, Simon GE, Oliver M, Ciechanowski P, Ludman EJ, Bush T, Young B. Relationship of depression and diabetes self-care, medication adherence, and preventive care. Diabetes Care 2004;27(9):2154-2160.
37. Pratt SI, Mueser KT, Driscoll M, Wolfe R, Bartels SJ. Medication nonadherence in older people with serious mental illness: Prevalence and correlates. Psychiatric Rehabilitation Journal 2006;29(4):299-310.